<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03401814</url>
  </required_header>
  <id_info>
    <org_study_id>17-009021</org_study_id>
    <secondary_id>ROR1721</secondary_id>
    <nct_id>NCT03401814</nct_id>
  </id_info>
  <brief_title>Imaging Response to Immunotherapy and Radiation Therapy in Patients With Liver Metastases</brief_title>
  <official_title>Imaging Response to Immunotherapy and Radiation Therapy in Patients With Liver Metastases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients will be imaged with MRE at the time of the RT planning MRI, prior to the induction&#xD;
      of RT and immunotherapy. Research imaging will be in addition to standard imaging studies&#xD;
      performed at time points consistent with the standard of care (at the time of the RT planning&#xD;
      MRI and the first clinical follow-up). An additional MRE exam will be performed at the end of&#xD;
      treatment outside the standard of care imaging.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2, 2018</start_date>
  <completion_date type="Actual">December 12, 2019</completion_date>
  <primary_completion_date type="Actual">December 12, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quantify tissue mechanical properties of the liver and liver tumor using MRE in patients receiving radiation therapy + immunotherapy at baseline, mid-treatment and time of followup imaging determined by standard of care to assess response to therapy</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <enrollment type="Actual">1</enrollment>
  <condition>Liver Metastases</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Magnetic Resonance Elastography</intervention_name>
    <description>rapidly developing technology for quantitatively assessing the mechanical properties of tissue, using externally applied mechanical waves</description>
    <other_name>MRE</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Radiation patients with liver metastases&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Diagnosis of solid cancers with the presence of one or more liver metastases&#xD;
&#xD;
          -  Minimum metastasis diameter ≥ 2 cm&#xD;
&#xD;
          -  Planning to receive radiation therapy with immunotherapy&#xD;
&#xD;
          -  Willingness to participate in mandatory imaging studies at Mayo Clinic Rochester&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindications for MRI including claustrophobia, pace maker, metal implants,&#xD;
             aneurism clips&#xD;
&#xD;
          -  Patients who are not able to consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Sean Park, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 10, 2018</study_first_submitted>
  <study_first_submitted_qc>January 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2018</study_first_posted>
  <last_update_submitted>July 8, 2021</last_update_submitted>
  <last_update_submitted_qc>July 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Sean S. Park</investigator_full_name>
    <investigator_title>Radiation Oncology Consultant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

